BSE Live
Jan 27, 16:01Prev. Close
67.05
Open Price
66.00
Bid Price (Qty.)
65.65 (1)
Offer Price (Qty.)
72.49 (50)
NSE Live
Jan 27, 15:58Prev. Close
66.40
Open Price
66.00
Bid Price (Qty.)
68.54 (165)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 08 | Mar 07 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 2.74 | 1.93 | |
| Diluted EPS (Rs.) | 2.74 | 1.93 | |
| Cash EPS (Rs.) | 4.52 | 3.99 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 33.54 | 31.98 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 33.54 | 31.98 | |
| Revenue from Operations/Share (Rs.) | 82.07 | 67.78 | |
| PBDIT/Share (Rs.) | 7.66 | 7.05 | |
| PBIT/Share (Rs.) | 6.10 | 5.69 | |
| PBT/Share (Rs.) | 3.49 | 3.09 | |
| Net Profit/Share (Rs.) | 2.74 | 1.93 | |
| NP After MI And SOA / Share (Rs.) | 2.74 | 1.93 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 9.33 | 10.40 | |
| PBIT Margin (%) | 7.43 | 8.38 | |
| PBT Margin (%) | 4.25 | 4.56 | |
| Net Profit Margin (%) | 3.33 | 2.84 | |
| NP After MI And SOA Margin (%) | 3.33 | 2.84 | |
| Return on Networth/Equity (%) | 8.15 | 6.03 | |
| Return on Capital Employed (%) | 4.38 | 3.84 | |
| Return on Assets (%) | 2.62 | 2.22 | |
| Total Debt/Equity (X) | 1.29 | 1.06 | |
| Asset Turnover Ratio (%) | 78.77 | 78.20 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.33 | 1.40 | |
| Quick Ratio (X) | 0.75 | 0.77 | |
| Inventory Turnover Ratio (X) | 3.37 | 2.96 | |
| Dividend Payout Ratio (NP) (%) | 36.56 | 38.84 | |
| Dividend Payout Ratio (CP) (%) | 22.12 | 18.77 | |
| Earnings Retention Ratio (%) | 63.44 | 61.16 | |
| Cash Earnings Retention Ratio (%) | 77.88 | 81.23 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 2.34 | 2.19 | |
| Interest Coverage Ratios (Post Tax) (%) | 2.34 | 2.19 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 69.98 | 61.64 | |
| EV/Net Operating Revenue (X) | 0.82 | 0.87 | |
| EV/EBITDA (X) | 8.74 | 8.37 | |
| MarketCap/Net Operating Revenue (X) | 0.32 | 0.38 | |
| Retention Ratios (%) | 63.43 | 61.15 | |
| Price/BV (X) | 0.79 | 0.81 | |
| Price/Net Operating Revenue | 0.32 | 0.38 | |
| Earnings Yield | 0.10 | 0.07 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y